MaxCyte shares rise amid double-digit revenue increase marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
Crystal Amber Fund Ltd - invests in small and mid-cap UK.
TRADING UPDATES: MaxCyte inks deal with Be Bio; Orcadian firms farmout | Finance News shareprices.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from shareprices.com Daily Mail and Mail on Sunday newspapers.
TRADING UPDATES: MaxCyte inks deal with Be Bio; Orcadian firms farmout lse.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lse.co.uk Daily Mail and Mail on Sunday newspapers.
NEWPORT BEACH, Calif. (BUSINESS WIRE) #RP jCyte, Inc., a pioneering biotechnology company dedicated to preserving and restoring vision in patients with retinitis pigmentosa (RP) and other degenerative retinal disorders, is pleased to announce the successful outcome of its pre-phase 3 Type B meeting with the US Fo.